Compare SY & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SY | RWAY |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.7M | 226.3M |
| IPO Year | 2018 | N/A |
| Metric | SY | RWAY |
|---|---|---|
| Price | $2.16 | $6.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $5.50 | ★ $9.50 |
| AVG Volume (30 Days) | 205.3K | ★ 513.1K |
| Earning Date | 05-15-2026 | 05-07-2026 |
| Dividend Yield | 0.91% | ★ 21.54% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $38.64 | $1.26 |
| Revenue Next Year | $30.63 | $1.25 |
| P/E Ratio | ★ N/A | $5.70 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.28 | $5.19 |
| 52 Week High | $5.35 | $11.14 |
| Indicator | SY | RWAY |
|---|---|---|
| Relative Strength Index (RSI) | 64.48 | 62.22 |
| Support Level | $1.68 | $5.25 |
| Resistance Level | $2.15 | $6.97 |
| Average True Range (ATR) | 0.16 | 0.14 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 80.46 | 90.65 |
So-Young International Inc is an aesthetic treatment platform in China connecting consumers with online services and offline treatments. Its online platform operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website, where both consumers and aesthetic practitioners can access media content, an engaging social community and a transparent reservation system. The company has four reportable segments: Aesthetic treatment services group, Platform service group, Wuhan Miracle, and Others. The majority of revenue is derived from the Platform service group, which generates revenue by providing information services and reservation services. All the company's revenues are derived from within the PRC.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States. The company's investment objective is to maximize its total return to its stockholders through current income on its loan portfolio, and secondarily through capital gain on its warrants and other equity positions.